Molecular and cellular basis of the renal diseases associated with Alagille Syndrome
阿拉吉尔综合征相关肾脏疾病的分子和细胞基础
基本信息
- 批准号:10209370
- 负责人:
- 金额:$ 36.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-01 至 2026-02-28
- 项目状态:未结题
- 来源:
- 关键词:AddressAlagille SyndromeAllelesCell Culture TechniquesCell divisionCell physiologyCellular AssayChildChronic Kidney FailureCiliaCodeCongenital AbnormalityCystCystic kidneyDNA Sequence AlterationDefectEnd stage renal failureEnhancersEnsureEpithelialEpithelial CellsExonsGenesGeneticGenetic ModelsGenetic VariationGenomeHead CancerHealthHumanKidneyKidney DiseasesKnowledgeLengthLifeLigandsLinkMaintenanceMalignant neoplasm of lungMediatingMediator of activation proteinMethodsMolecularMulticystic Dysplastic KidneyMusMutationNeck CancerNotch Signaling PathwayPathogenicityPathway interactionsPatientsPenetrancePeptidesPhenotypePlantsProcessProteinsRenal carcinomaReportingRepressionRetrospective StudiesScaffolding ProteinSeveritiesSignal TransductionSignaling ProteinSkin CancerStructureSyndromeTestingTumor Suppressor ProteinsUrinary tractVariantautosomal dominant mutationcell typecongenital anomalyexome sequencingimprovedkidney cellkidney epithelial cellmouse modelmutantnephrogenesisnephron progenitornotch proteinnotch-2 proteinnovelpreventrare variantreceptorrenal epitheliumsmall moleculestem
项目摘要
Project Summary
The leading cause of end stage renal disease among children under 5 years is congenital abnormalities of the
kidney and urinary tract (CAKUT). Among the several genetic mutations that have been linked to CAKUT are
mutations in Notch signaling pathway genes, JAG1 and NOTCH2. Mutations in these Notch pathway genes are
predicted to reduce the level of Notch signaling activity, and are associated with Alagille Syndrome (ALGS). One
component of ALGS is the variable occurrence of kidney disease including that of small multicystic, dysplastic
kidneys. For instance, a retrospective study determined that 40% of ALGS patients with JAG1 mutations had
some form of kidney disease with dysplastic kidneys with or without cysts occurring in 60% of ALGS patients
with kidney disease. The underlying cellular and molecular mechanisms by which Notch signaling ensures
normal kidney development and maintenance are poorly understood. We know that JAG1 can function as a
ligand to activate NOTCH2, and assume the canonical Notch signaling pathway prevents kidney disease
associated with ALGS. However, mutations in the other canonical Notch signaling pathway components have
not been associated with ALGS. Additionally, the high degree of variability in the manifestation of kidney disease
among ALGS patients is puzzling. In our mouse models the severity of multi-cystic kidney disease increases
with increasing number of Notch1 and Notch2 alleles inactivated in the developing renal epithelium. Here we
propose to determine the Renal Epithelial Notch Signaling Network (RENSN) and perform whole exome
sequencing of ALGS patients to determine if additional variations in RENSN genes in addition to JAG1 and/or
NOTCH2 determine the occurrence of multicystic/dysplastic kidneys in ALGS. Additionally, we will test if
NOTCH2 mutations associated with ALGS alter the orientation of renal epithelial cell division, primary cilia
structure and expression of renal epithelial Notch target genes in different renal epithelial cell cultures. We will
also determine the proximal interacting proteins of wild type versus ALGS associated NOTCH2 variants using
BioID. Additionally, we will apply three strategies to molecularly intervene and prevent the Notch-signaling-
deficient kidney defects. These studies will establish the underlying cellular and molecular mechanisms of kidney
disease associated with ALGS and identify methods to increase Notch signaling specifically in kidney cell types
by determining the molecular interface between Notch signaling and renal epithelial functions.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kameswaran Surendran其他文献
Kameswaran Surendran的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kameswaran Surendran', 18)}}的其他基金
Molecular and cellular basis of the renal diseases associated with Alagille Syndrome
阿拉吉尔综合征相关肾脏疾病的分子和细胞基础
- 批准号:
10617239 - 财政年份:2021
- 资助金额:
$ 36.52万 - 项目类别:
Molecular and cellular basis of the renal diseases associated with Alagille Syndrome
阿拉吉尔综合征相关肾脏疾病的分子和细胞基础
- 批准号:
10399602 - 财政年份:2021
- 资助金额:
$ 36.52万 - 项目类别:
Molecular Regulators of Renal Collecting Duct Differentiation and Maintenance
肾集合管分化和维持的分子调节剂
- 批准号:
9305081 - 财政年份:2016
- 资助金额:
$ 36.52万 - 项目类别:
Molecular Regulators of Renal Collecting Duct Differentiation and Maintenance
肾集合管分化和维护的分子调节剂
- 批准号:
9173773 - 财政年份:2016
- 资助金额:
$ 36.52万 - 项目类别:
The cellular and molecular mechanisms regulating renal proximal tubule morphogenesis
调节肾近曲小管形态发生的细胞和分子机制
- 批准号:
8725207 - 财政年份:
- 资助金额:
$ 36.52万 - 项目类别:
The cellular and molecular mechanisms regulating renal proximal tubule.........
调节肾近曲小管的细胞和分子机制.........
- 批准号:
8465608 - 财政年份:
- 资助金额:
$ 36.52万 - 项目类别:
相似海外基金
Resolving Uncertainty in Alagille Syndrome Diagnostics
解决阿拉吉尔综合征诊断中的不确定性
- 批准号:
10734881 - 财政年份:2023
- 资助金额:
$ 36.52万 - 项目类别:
Augmented Notch signaling as a therapeutic approach for Alagille Syndrome
增强型 Notch 信号传导作为 Alagille 综合征的治疗方法
- 批准号:
10504974 - 财政年份:2022
- 资助金额:
$ 36.52万 - 项目类别:
Augmented Notch signaling as a therapeutic approach for Alagille Syndrome
增强型 Notch 信号传导作为 Alagille 综合征的治疗方法
- 批准号:
10672969 - 财政年份:2022
- 资助金额:
$ 36.52万 - 项目类别:
Alagille Syndrome Scientific Meeting - Measuring What Matters
阿拉吉尔综合症科学会议 - 衡量重要的事情
- 批准号:
10469076 - 财政年份:2022
- 资助金额:
$ 36.52万 - 项目类别:
Targeting POGLUT1 to promote biliary development in Alagille syndrome
靶向 POGLUT1 促进 Alagille 综合征胆道发育
- 批准号:
10449607 - 财政年份:2022
- 资助金额:
$ 36.52万 - 项目类别:
Molecular and cellular basis of the renal diseases associated with Alagille Syndrome
阿拉吉尔综合征相关肾脏疾病的分子和细胞基础
- 批准号:
10617239 - 财政年份:2021
- 资助金额:
$ 36.52万 - 项目类别:
Molecular and cellular basis of the renal diseases associated with Alagille Syndrome
阿拉吉尔综合征相关肾脏疾病的分子和细胞基础
- 批准号:
10399602 - 财政年份:2021
- 资助金额:
$ 36.52万 - 项目类别:
Combined genetic analyses can achieve efficient diagnostic yields for subjects with Alagille syndrome
结合遗传分析可以对阿拉吉勒综合征受试者实现有效的诊断率
- 批准号:
17K11516 - 财政年份:2017
- 资助金额:
$ 36.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Negative regulation of Jagged1 by glycosylation: towards a mechanism-based therapy for Alagille syndrome
糖基化对 Jagged1 的负调控:针对 Alagille 综合征的基于机制的治疗
- 批准号:
9310392 - 财政年份:2016
- 资助金额:
$ 36.52万 - 项目类别:
Genetic Modifiers of Liver Disease Severity in Alagille Syndrome
阿拉吉尔综合征肝病严重程度的基因修饰
- 批准号:
7883529 - 财政年份:2009
- 资助金额:
$ 36.52万 - 项目类别: